Nexcyon is an independent, privately held pharmaceutical company that is dedicated to advancing veterinary medicine and strengthening the bond between humans and animals worldwide. With a focus on breakthrough science, true innovation, and a holistic approach, Nexcyon strives to improve the health and well-being of both humans and their companion animals. Recognizing the profound impact that animals have on our lives, with approximately 90 million dogs and 95 million cats in the United States alone, Nexcyon believes in the importance of integrating human and veterinary medicine.

By sharing environments, physiology, and infectious agents, the connection between human and animal health is evident. Nexcyon aims to leverage this integration to develop new medical interventions and improve outcomes for both groups. Through their dedicated efforts in discovery, development, and collaboration, Nexcyon focuses on new diagnostics, molecular genetics, vaccines, small molecule therapeutics, biopharmaceuticals, and delivery technologies.

This comprehensive approach allows them to provide innovative solutions for the veterinary field. Join Nexcyon in their mission to make a positive impact on the world of veterinary medicine and strengthen the special bond between humans and animals. Contact them today to learn more about their partnership opportunities and join their team of dedicated professionals